Increasing HIV testing for young children in rural Uganda
Official title: Improving HIV testing among Children under five in Rural Uganda
Funded at University of California, San Francisco · NIH-10839225 · Data updated 2026-11-12
This study is working to help more young children in rural Uganda get tested for HIV by teaming up with trusted local healers, so they can find out about any barriers to testing and make it easier for families to access these important health services.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $431,712 |
| NIH project number | 1R21MH135815-01A1 |
| Project ID | NIH-10839225 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children aged 18 months to 5 years living in rural Uganda who may be at risk for HIV.
✕Less likely to help
Patients outside the age range of 18 months to 5 years or those not residing in rural Uganda may not benefit from this research.
What this research studies
This research aims to improve HIV testing rates among children aged 18 months to 5 years in rural Uganda by collaborating with traditional healers who are trusted figures in the community. The study will identify barriers to testing and adapt a previously successful program that increased testing among adults. By engaging traditional healers, the project seeks to facilitate access to HIV testing for young children, ensuring that more cases are diagnosed and treated early. The approach will involve interviews and community engagement to tailor the program effectively.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and treatment of HIV in young children, significantly improving their health outcomes.
How similar studies have gone: Previous research has shown success in increasing HIV testing rates through partnerships with traditional healers in similar contexts.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Hooft, Anneka M — University of California, San Francisco
- Study coordinator: Hooft, Anneka M
Related research
Other NIH-funded projects on the same topics.
-
How cancer cells use exosomes to evade the immune system
This study is looking at how cancer cells use tiny bubbles called exosomes to hide proteins that can keep your immune system from fighting the tumor, and by figuring this out, the researchers hope to help doctors understand why some people respond well to cancer treatments while others don’t, ultimately aiming to creat
-
Reducing harm from smoking using electronic cigarettes
This study is looking at whether using electronic cigarettes can be a safer option for people who smoke traditional cigarettes, by comparing the health effects and exposure to harmful substances between the two.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Cutaneous opioid signals in skin inflammation
A mentor-identified clinician-researcher at UCSF is studying how natural skin opioids regulate itch and pain in inflammatory skin conditions like eczema and hidradenitis, with plans to map where these opioids come from and how they affect skin nerves.
-
Pooling international data to understand long-term bisphosphonate use and atypical femur fractures
This project combines large patient datasets from multiple countries to understand how long-term bisphosphonate use relates to rare hip and thigh bone fractures, helping doctors and patients make safer treatment choices.
-
Airway cell and immune cell talks in lung transplant failure
This grant tests how airway cells and immune cells interact to drive chronic rejection after lung transplant, with the goal of slowing or preventing scar-like damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.